EUCTR2011-001266-17-Outside-EU/EEA进行中（未招募）不适用
An open-label extension study of the long-term safety,tolerability and efficacy of GSK2402968 in subjects withDuchenne Muscular Dystrophy - N/A
GlaxoSmithKline Research and Development LTD0 个研究点目标入组 32 人开始时间: 2012年3月9日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 32
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Male
入选标准
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
不适用
An open-label extension study of the long-term safety and efficacy of rosiglitazone extended-release (RSG XR) as adjunctive therapy to acetylcholinesterase inhibitors in subjects with mild-to-moderate Alzheimer's disease (REFLECT-4). - REFLECT-4EUCTR2006-004152-20-DEGlaxoSmithKline Research & Development Ltd1,500
进行中（未招募）
不适用
An open-label extension study of the long-term safety and efficacy of rosiglitazone extended-release (RSG XR) as adjunctive therapy to acetylcholinesterase inhibitors in subjects with mild-to-moderate Alzheimer's disease (REFLECT-4).Alzheimer’s disease,MedDRA version: 9.1Level: LLTClassification code 10001896Term: Alzheimer's diseaseEUCTR2006-004152-20-ATGlaxoSmithKline Research & Development Ltd1,500
进行中（未招募）
不适用
An open-label extension study of the long-term safety,tolerability and efficacy of GSK2402968 in subjects with Duchenne Muscular DystrophyMedDRA version: 14.1Level: PTClassification code 10013801Term: Duchenne muscular dystrophySystem Organ Class: 10010331 - Congenital, familial and genetic disordersDuchenne Muscular DystrophyEUCTR2011-001266-17-HUGlaxoSmithKline Research and Development LTD200
进行中（未招募）
1 期
An extension study of a drug to treat Chronic Thromboembolic Pulmonary Hypertension (CTEPH)subjects with inoperable chronic thromboembolic pulmonary hypertension (CTEPH)MedDRA version: 14.1 Level: LLT Classification code 10068739 Term: Chronic thromboembolic pulmonary hypertension System Organ Class: 100000004855EUCTR2012-001642-17-GBGlaxoSmithKline Research & Developement Ltd19
进行中（未招募）
不适用
An open-label extension study of the long-term safety and efficacy of rosiglitazone extended-release (RSG XR) as adjunctive therapy to acetylcholinesterase inhibitors in subjects with mild-to-moderate Alzheimer's disease (REFLECT-4).Alzheimer’s disease,MedDRA version: 9.1Level: LLTClassification code 10001896Term: Alzheimer's diseaseEUCTR2006-004152-20-CZGlaxoSmithKline Research & Development Ltd1,350